Table 2.
AAPOS 2021 ARF | Prevalence | Cohort | IRC Medium (Sensitive, Specific) | Referral Rate | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AGE | Hyperopia | Anisometropia | Cylinder | Myopia | Hyperopia | Anisometropia | Cylinder | Myopia | Sensitive | Medium | Specific | ||
<4 | >4 | >1.25 | >3 | <-3 | 22% | Plusoptix | 3(2.5,3.5) | 1.75(1.5,1.75) | 3.5(3.25,3.75) | −3.5(−3.25,-3.5) | 30% | 24% | 21% |
<4 | >4 | >1.25 | >3 | <-3 | 30% | SPOT | 1.75(1.5,2) | 1.5(1.25,1.75) | 3.25(3,3.5) | −3.5(−3.25,-3.75) | 31% | 28% | 27% |
<4 | >4 | >1.25 | >3 | <-3 | 36% | 2WIN | 2.5(2,2.75) | 1.75(1.5,2) | 3.5(3.25,3.75) | −3.5(−3.25,-3.75) | 41% | 33% | 28% |
≥4 | >4 | >1.25 | >1.75 | <-2 | 34% | Plusoptix | 3(2.5,3.5) | 1.75(1.25,1.75) | 2.5(2.25,2.75) | −2.5(−2,-2.5) | 41% | 35% | 32% |
≥4 | >4 | >1.25 | >1.75 | <-2 | 43% | SPOT | 1.75(1.5,2) | 1.5(1.25,1.75) | 2.25(2,2.5) | −2(−1.75,-2.5) | 41% | 37% | 34% |
≥4 | >4 | >1.25 | >1.75 | <-2 | 54% | 2WIN | 2(1.5,2.5) | 1.5(1.25,1.75) | 2.5(2.25,2.75) | −2(−1.75,-2.5) | 51% | 44% | 39% |